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Abstract
Background: Leishmania infantum is the parasite responsible for the disease in humans known as zoonotic visceral
leishmaniasis (ZVL). Dogs are considered the main domestic reservoir of ZVL and sand flies are the proven vectors.
The use of systemic insecticides in dogs has been studied as an alternative strategy to control ZVL in endemic areas.
One systemic insecticide in dogs, fluralaner, has a proven anti-sand fly effect in membrane-fed studies. However, the
efficacy and duration on sand flies directly feeding from dogs treated with fluralaner remains unknown.
Methods: Direct feeding bioassays were performed on 10 beagle dogs that had been randomly assigned to two
groups: one with five dogs orally treated with Bravecto® (fluralaner) and other five as a control. About 30 females of
Phlebotomus papatasi were allowed to directly feed from dogs at seven days before the administration of the
treatment and Days 3, 17, 31, 45 and 73 post-treatment. Sand fly mortality after feeding was observed every 24 h for
5 days. The Kaplan-Meyer method, Henderson-Tilton formula and a negative binomial mixed model were used to
respectively calculate: (i) mortality and its 95% confidence interval (CI); (ii) efficacy of the insecticide at killing sand flies
in 24 h; and (iii) differences in the risk of sand fly death at 24 h after feeding.
Results: Control sand fly mortality 24 h after feeding was always ≤ 20% and mortality in the fluralaner group ranged
from 2% (95% CI: 0–4%) 7 days before treatment to 100% at 3 days post-treatment. Fluralaner efficacy was 100, 93, 94
and 75% at Days 3, 17, 31 and 45, respectively (P < 0.0001). The increase in the risk of sand fly death was 32.9 (95% CI:
4–263), 76 (95% CI: 8–705), 95.8 (95% CI: 9–1029) and 10.6 times (95% CI: 1.43–79) on Days 3, 17, 31 and 45, respectively
Conclusions: The efficacy of fluralaner, orally administered to dogs, against sand-flies was above 90% for 31 days.
Fluralaner administered to dogs should be further evaluated as a control strategy in ZVL endemic areas.
Keywords: Zoonotic visceral leishmaniasis (ZVL), Sand flies, Dogs, Systemic insecticides, Fluralaner
Background
Fluralaner is a systemic insecticide from the ixosazoline
group used for the control of ectoparasites in compan-
ion animals. Bravecto® is the commercialized name of
flavored chewable tablets of fluralaner (25 mg/kg body
weight) registered for dogs to control fleas and ticks
infestations for 12 weeks [1]. Fluralaner belongs to the
isoxazoline group. Isoxazolines act at the central nervous
system or the neuromuscular junction of the insect
blocking GABA-gated chloride channels, thus disrupting
neuronal signaling and muscle regulation causing insect
death [2, 3]. Based on the mechanism of action, flurala-
ner and other systemic insecticides used in dogs may
have an anti-sand fly effect [4, 5]. The effect of fluralaner
on sand fly mortality was demonstrated in a randomized
clinical trial in dogs using membrane feeding bioassays
[6]. This proof of concept study reported sand fly
mortalities between 60–80% for 30 days in dogs treated
with fluralaner [6]. However, the high sand fly mortality
in the control group precluded accurately estimating the
mortality caused by fluralaner. Membrane-feeding was
also used to demonstrate that fluralaner, mixed with* Correspondence: soniaares@gmail.com; albert.picado@isglobal.org
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rabbit blood, was effective against different species of
sand flies [5].
Some species of sand flies are the vectors of
Leishmania infantum, the parasite causing zoonotic vis-
ceral leishmaniasis (ZVL). ZVL is a major public health
concern in some countries and regions (e.g. 3000 cases
with 10–19% lethality in Brazil per year [7]). Dogs,
which are also affected by the parasite, are the main res-
ervoir and they are often targeted by the leishmaniasis
control programs in endemic countries. In Brazil, L.
infantum infected dogs are culled to reduce the source
of infection [7]. This strategy is controversial and has
had a limited impact on the number of ZVL cases in
humans [8–10]. The use of insecticide-impregnated
collars in dogs [11–13] has been evaluated as an
alternative to dog culling. Community-wide use of
insecticide-impregnated collars has been proven to
reduce the risk of L. infantum infection in humans
[13, 14] but its use at a regional or national level has
been limited due to several factors, namely the price
of collars, collar losses, collar removal by dogs owners and
high percentage of unreachable stray dogs [12, 14, 15].
Other topical insecticides in dogs such as topical lotions
of deltamethrin, permethrin and fenthion, have also been
suggested in vector control [16, 17]. The use of systemic
insecticides in dogs has been proposed as a vector
control tool in endemic regions. A modelling study
showed that treating 80% of dogs with a systemic in-
secticide that induces a sand fly mortality over 65%
for 7.4 months would reduce the risk of L. infantum
infection in humans by 80% [18].
To the best of our knowledge, there are currently no
systemic insecticides for dogs registered against sand
flies. Fluralaner, which can be given orally, is registered
for dogs against ticks and fleas and has a proven
anti-sand fly effect [5], could be a good control tool for
ZVL in endemic areas [4, 18] In fact, Miglianico et al.
[5] suggested the repurposing of fluralaner so it can be
used in humans to control leishmaniasis and other
vector-borne diseases. To further evaluate the efficacy
and duration of fluralaner administered to dogs against
sand flies we performed a blinded, randomized clinical
trial using direct-feeding bioassays.
Methods
Study site and dogs
A total of 10 beagles (5 males and 5 females) between 12
and 24 months-old and weighting between 11–13 kg
were used. The dogs were obtained from a licensed
vendor and acclimatized to the study facility for more
than 40 days prior to the beginning of the study. Dogs
were uniquely identified by a subcutaneous microchip.
The dogs were housed in individual inside-outside ken-
nels that conformed to accepted guidelines for animal
welfare. Dogs were fed a commercial dry dog ration once
a day, water was provided ad libitum, and received regu-
lar exercise and social interaction. At the beginning of
the study all dogs were clinically healthy and not clinic-
ally pregnant as determined by a veterinarian. Dogs had
not been treated with drugs, baths, shampoos, or
pesticides within 4 weeks preceding the beginning of the
study and were not treated during the course of the
study other than with fluralaner in the treated group.
Study design
The study was designed to detect at least 65% insecticide
efficacy of fluralaner on blood-fed Phlebotomus papatasi
feeding on dogs, with a power of 0.8 and an alpha of
0.05.
Two groups of 5 dogs were randomly selected block-
ing by gender. Once two groups were formed, one with
3 females and 2 males and other with 2 females and 3
males, treatment was randomly assigned to one of the
groups. The random selection was done using the sam-
ple function in R [19].
At Day 0, the dogs in the treatment group received
one chewable tablet for medium-sized dogs (> 10 to 20
kg) of Bravecto®, equivalent to 500 mg of fluralaner, at
the time of feeding, as indicated in the label. Control
dogs received their regular ration only.
The effect of Bravecto® on sand flies was assessed using
direct-feeding bioassays at Days 3, 17, 31, 45 and 73.
Additionally, a direct feeding bioassay was performed 7
days before the administration of the treatment (Day -7).
Phlebotomus papatasi females, two- to seven-days-old
from a colony reared in the University of Zaragoza were
used in the direct-feeding bioassays. The colony was
established in 2012 with P. papatasi trapped in the prov-
ince of Zaragoza (Spain). The colony was maintained at
27 °C, 80% relative humidity and photoperiod of 17:7 h
(light:dark) [20].
On the days of the bioassay, fasted dogs were sedated
with 0.5 mg/kg of intramuscular dexmedetomidine
(Dexdomitor®). Once the dog was sedated, the previously
shaved inner part of the ear was exposed to the bite of
about 30 P. papatasi females. To facilitate the feeding
and the recovery of blood-fed sand flies during the
direct feeding bioassays [21, 22] the sand flies were in-
troduced in a round container (11.5 cm diameter and
7.5 cm height) covered by a cotton net that allowed
them to feed through (Fig. 1a). To keep the ear warm,
one bottle of 250 ml of normal saline previously warm
to 37 °C was placed on top (Fig. 1b). One hour or at
least 30 min later, when most of the females were
engorged, the sand flies were removed. The dogs re-
ceived one intramuscular injection of atipamezole (0.25
mg/kg, Antisedan®) to revert the anesthesia.
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For the ease of observation, engorged sand flies were
separated in groups of five into a plastic cup of 90 ml
and 60 mm diameter with sucrose solution provided
daily. The plastic cups were introduced into an incuba-
tor where humidity was controlled. Sand fly mortality
was observed every 24 h during five days. Sand fly
mortality and its 95% CI was calculated at each day for 5
days post-feeding using the Kaplan-Meyer method [23].
The researchers manipulating the sand flies and
observing sand fly mortality were blind to treatment
allocation.
Statistical analysis
Two methods were used to assess the sand fly mortality
due to fluralaner. The Henderson-Tilton formula was
used to estimate the efficacy of the insecticide at killing
sand flies [24], and a negative binomial mixed model
was used to estimate the risk of sand fly death due to
fluralaner over time [25]. Both analyses used the sand fly
mortality observed 24 h post-ingestion as the outcome.
Efficacy was measured as the percentage of sand fly
mortality due to the insecticide effect and was calculated
according to the following adapted Henderson-Tilton
formula [24, 26]:
Eficcacy %ð Þ
¼ 1− No: of engorged SF in Co  No: of SF alive in T after 24 h
No: of SF alive in Co after 24 h  No: of engorged SF in T
 
 100
where SF is sand flies, Co is control group and T is treat-
ment group. Fisher’s exact test was used for each experi-
mental day to test if differences in sand fly mortality were
significantly different at alpha 0.05. The European Medi-
cine Agency uses as reference method a similar formula
and efficacies above 80% should be achieved to demon-
strate efficacy of ectoparasiticides [27].
In negative binomial mixed model the variable that
identified each individual dog was included as random
effect [25]. The model explanatory variables were
treatment, day of study, and the interaction between
treatment and Day. The interaction term allowed us to
estimate differences in the sand fly mortality across time.
The model dependent variable was the log of the num-
ber of sand flies dead 24 h post-feeding given the total
number of engorged sand flies (offset). The exponential
of the model estimates represents the incidence rate
ratios (IRR) which indicate how many times the risk of
death increases due to fluralaner.
All analyses were conducted in R (version 3.3) [19].
The MASS package [28] was used to conduct the
negative binomial regression. The survival and coxme
packages [29] were used to conduct the Kaplan-Meier
table.
Results
The study was conducted between May and July 2018.
No adverse effects related to the treatment were
observed in any animal during the course of the study.
A total of 909 and 849 specimens of P. papatasi were
used in the treatment and control groups, respectively
(Table 1). Control sand fly mortality 24 h after feeding
was always ≤ 20% as established in the EU guidelines
[27]. Kaplan-Meyer mortality at 24 h post-feeding (%,
and 95% CI) per group and bioassay are reported in
Table 1; the data at 48, 72, 96 and 120 h post-feeding are
provided in Additional file 1: Table S1 and the data for
24 h sand fly mortality per dog are provided in
Additional file 1: Table S2. Sand fly mortality 24 h after
feeding in the control group ranged from 1% (95% CI:
Fig. 1 Direct feeding bioassay of Phlebotomus papatasi directly feeding on a sedated dog. a Detail of the inner part of the ear exposed to the
bite of about 30 P. papatasi females located inside a round container covered by a cotton net that allowed the sand flies to feed through.
b Sedated dog with the ear exposed to sand flies being warmed by a bottle of 250 ml of normal saline previously warm to 37 °C
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0–3%) to 20% (95% CI: 13–28%) corresponding to Days
31 and 73 respectively. Mortality in the fluralaner group
ranged from 2% (95% CI: 0–4%) at Day -7 (before
treatment) to 100% at Day 3 after treatment. At Days 17
and 31 the 24 h mortality and its 95% CI were above
90%. A decrease to 77% (95% CI: 72–82%) was observed
at Day 45 and a further drop to 42% (95% CI: 35–49%)
at Day 73 (Table 1).
Fluralaner showed efficacies of 100, 93 and 94% at
Days 3, 17 and 31, respectively (P < 0.0001; Table 1).
Between Days 45 (efficacy 75%; P < 0.0001) and 73
(29 %; P = 0.08) the efficacy dropped below the
threshold of 65% (Fig. 2).
Fluralaner highly increased the risk of sand fly death
(Table 2). The incidence rate ratio (IRR) was 32.9 (95%
CI: 4–263), 76 (95% CI: 8–705), 95.8 (95% CI: 9–1029)
and 10.6 (95% CI: 1.43–79) on Days 3, 17, 31 and 45, re-
spectively (Table 2). The sand fly killing effect of flurala-
ner decreased after Day 31 post-treatment and on Day
73 the effect was not significant (Fig 3).
Discussion
One oral dose of Bravecto® showed efficacies > 94% at
killing sand flies for 31 days and > 75 % for 45 days
post-treatment. The sand fly risk of death 24 h after
feeding increases more than 10 times when feeding from
a treated dog and this effect was maintained for 45 days
after treatment.
The efficacy of fluralaner administered to dogs at kill-
ing sand flies has already been demonstrated in a
membrane-feeding study [6]. However, the mentioned
study reported lower mortalities in the fluralaner group
Table 1 Observed efficacy and induced mortality of fluralaner against sand flies 24 hours after exposure on dogs
Direct feeding Control Fluralaner
na Deathsb
n (%)





Day -7 138 3 (2) 0–5 123 2 (2) 0–4 0 0.75
Day 3 147 6 (4) 0–7 151 151 (100) nae 100 <0.0001
Day 17 150 3 (2) 0–4 146 143 (98) 96–100 93 <0.0001
Day 31 148 2 (1) 0–3 159 150 (95) 91–98 94 <0.0001
Day 45 141 13 (10) 5–15 148 138 (89) 84–93 75 <0.0001
Day 73 153 34 (22) 13–28 182 75 (42) 35–49 26 <0.08
aNumber of sand flies exposed to direct-feed on dogs
bNumber (%) of sand flies dead 24 h after direct-feeding
cEfficacy as the percentage of phlebotomine mortality due to the insecticide effect calculated according to adapted Henderson-Tilton’s formula
d(Two-sided) probability values associated with the comparison on sand fly mortality between control and fluralaner using Fisher’s exact test
eAll samples showed 100% death so there is no 95% CI
Fig. 2 Corrected efficacy (%) according to Henderson-Tilton’s
formula for Phlebotomus papatasi 24 h after feeding on dogs treated
with one chewable tablet of Bravecto® on Days 3, 17, 31, 45 and 73
after treatment. The interrupted line indicates the efficacy threshold
of 65%
Table 2 Negative binomial mixed model results including
treatment group, experimental day and their interaction as fixed
effects and dog as random effect. The incidence rate ratio (IRR)
represents the increase in the rate of incidence compared with
control per day
Explanatory variablea IRRb 95% CI P-value
Day -7 0.75 0.09–4.85 0.77
Day 3 32.87 4.09–263 0.001**
Day 17 76.06 8.20–705 0.0002**
Day 31 95.85 8.92–1029 0.0002**
Day 45 10.66 1.43–79 0.02*
Day 73 2.50 0.34–18 0.36
aThe explanatory variables used control group at each corresponding day after
treatment as baseline comparison (Pr(>|z|))
bIncidence rate ratio, as the ratio between the incidence rate in control group
and the incidence rate for each treatment group, at the corresponding
experimental day after treatment
*Significance level at α = 0.05
**Significance level at α = 0.001
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(42–80%) and higher mortalities in the control group
(35–60%). These discrepancies with our results could
be due to the manipulation of the blood samples
(freeze-thaw) made during the membrane-feeding
study [30]. A recent laboratory study evaluated the
IC50 (concentration at which 50% of the sand flies
died 24 h after feeding) of fluralaner for two sand fly
species, Lutzomyia longipalpis (vector of L. infantum
in Latin America) and P. argentipes (vector of L.
donovani in the Indian subcontinent). Lutzomyia long-
ipalpis required twice the dose of fluralaner [655 ng/
ml (95% CI: 537–796)] to kill 50% of the sand flies
compared to P. argentipes [318 ng/ml (95% CI: 278–
364)]. Bravecto® demonstrated a plasma concentration
of fluralaner maintained above 650 ng/ml for 40 days
and above 350 ng/ml, for 56 days post-treatment
[1, 3, 31]. Our study found P. patatasi mortality
above 75% for 45 days post-treatment. Phlebotomus
papatasi has shown to be as susceptible to fluralaner
as P. argentipes and more susceptible than L. longi-
palpis. In the Old World, P. perniciosus is the main
vector of L. infantum, thus the experiment should
have ideally been performed using a colony of P. per-
niciosus. However, the trial required a total of 1800
females and unfortunately the colony of P. perniciosus in
the University of Zaragoza could not produce this number
of sand flies; as such we had to use P. papatasi instead.
Based on a previous study we expect similar insecticide
sensitivity between P. papatasi and P. perniciosus [32].
Because a higher concentration of fluralaner is needed to
control L. longipalpis, a shorter period of action of
Bravecto® could be expected in this sand fly species.
Additionally, Bravecto® administered to dogs also induced
100% triatomine mortality for 51 days [21].
Conclusions
A single chewable tablet of fluralaner was effective
against sand flies feeding on treated dogs for 45 days
(efficacy > 75%). The community-wide use of fluralaner
and other isoxazoline drugs registered for dogs such as
afoxolaner or saloraner should be evaluated as a ZVL
control strategy in endemic areas.
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and sampling day. Table S2. Individual dog sand fly mortality and
percentage observed 24 h after direct blood-feeding by treatment and
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